Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer
Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer
About this item
Full title
Author / Creator
Publisher
Japan: Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Japan: Springer Japan
Subjects
More information
Scope and Contents
Contents
Objective
To evaluate the efficacy and toxicity of third-line gemcitabine monotherapy (Gem) in patients with platinum-resistant advanced urothelial cancer (UC).
Patients and methods
From July 2005 to March 2009, 13 patients were enrolled. All patients had previously received methotrexate, vinblastine, doxorubicin, and cisplatin as first-li...
Alternative Titles
Full title
Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_746319017
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_746319017
Other Identifiers
ISSN
1341-9625
E-ISSN
1437-7772
DOI
10.1007/s10147-010-0071-8
